| http://www.w3.org/ns/prov#value | - The European Commission approved the new use in April.The regulatory applications were based on clinical data showing that Humira improved rates of disease remission versus a placebo in people with colitis, an inflammatory bowel disease that causes pain, diarrhea and other symptoms.Humira is currently approved in the U.S. to treat rheumatoid arthritis and several other inflammatory conditions.
|
